Introduction
A little over 10 years ago when my colleagues and I started to work on amino acid transport in muscle, the available information (e.g. [ 1-31) been reviewed elsewhere [ll]. In this paper we will concentrate on more recent aspects of our findings.
was largely confined to descriptions of tracer uptake of a handful of amino acids, including a number of non-metabolizable amino acid analogues such as aminoisobutyric acid and methylaminoisobutyric acid. We set to work to define, in a systematic fashion, the characteristics of the transport of a variety of amino acids, using perfused skeletal muscle [4, 5] , muscle plasmamembrane vesicle preparations [6, 7] and muscle culture systems [8]. We were particularly interested in relating the characteristics of the transporters to the involvement of amino acids in the whole body fuel and nitrogen economy. For one amino acid in particular, glutamine, this approach has paid dividends, since we have found that it occupies a pivotal position in the modulation of local and whole body metabolism, partly as a result of activities involving its transport. It seems remarkable that a simple organic compound such as glutamine should be able to act as a signal, as a modulator, as a synthetic precursor, as a fuel and even, when it is provided in large amounts, as a so-called neutraceutical which can protect low-birth-weight infants from infection [9] and decrease morbidity and mortalitv in intensive care patients [lo].
Our earlier work on characteristics of amino acid transport in skeletal muscle and heart has
Amino acids as modulators of amino acid transporter activities
Glutamine synthetase and Na+-dependent transport of glutamate and glutamine in skeletalmuscle myotubes appear to show co-ordinated up-regulation when cells are deprived of extracellular glutamine and down-regulation after glutamine resupplementation [ 12,131. The major transporters involved are System N" for glutamine and a low-affinity form of System for glutamate. Glutamine transport is also up-regulated if intracellular glutamine concentration is decreased by inhibiting muscle glutamine synthetase [12]. T h e mechanisms involved appear to respond only to changes in availability of System N" substrates (glutamine, asparagine, histidine) and are blocked by inhibitors of protein translation and DNA transcription. This form of 'adaptive regulation' may represent a co-ordinated response by muscle to decreased glutamine availability, for example under circumstances of increased glutamine utilization by other tissues in vivo. In contrast, branchedchain amino acids (principally leucine) activate Na+-dependent System A amino acid transport in L6 rat skeletal-muscle cells [14] by a mechanism involving transcriptional regulation. This observation is consistent with the known anabolic effects of leucine on protein turnover in skeletal muscle [15, 16] but must reflect the operation of a mechanism distinct from the 'adaptive regulation' described above for glutamine (not least because transport by System A represents a minor component of leucine entry into muscle [5] ). These contrasting effects of leucine and glutamine on different amino acid-transport systems highlight the importance of particular nutrients as modulators of specific cellular processes and metabolic pathways through regulation of gene transcription.
Glutamine transport in heart and the cardioprotective and rescue properties of glutamine
After having characterized skeletal-muscle amino acid transport, we naturally turned to a consideration of the heart. We were particularly interested in the relationship between glutamate and glutamine transport, since it had previously been reported that high glutamate concentrations in cardioplegia solutions or infusions given during cardiac reperfusion could prevent or ameliorate hypoxic or ischaemic damage [17] . We hypothesized that, if heart were like skeletal muscle, glutamine should be transported much faster than glutamate, and, since heart contains glutaminase, then if intracardiac glutamate concentrations could be sustained by rapid delivery and subsequent hydrolysis of glutamine present at low extracellular concentrations, this could have important beneficial effects. Our work in porcine cardiac sarcolemmal vesicles [ 181 indicated that the transporters for glutamate, glutamine and also histidine showed characteristics distinct from those observed in other tissues such as skeletal muscle [4, 8, 13] and liver [19] . For example, although the cardiac glutamine transporter is Nat -dependent and shows strong mutual inhibition by 1,-histidine, unlike its skeletal muscle counterpart it is not Li+-tolerant, indicating that cardiac glutamaine transport occurs via a transporter different from the known System N" [6, 8] . Furthermore, the Na+-dependent stereoselective cardiac glutamate transporter is not inhibited by the D-isomers of either glutamate or aspartate, the latter being a distinct characteristic of the previously described anionic amino acid carrier & -i
[ZO]. This feature indicates that LPG is not the major cardiac glutamate transporter. In skeletal muscle the major glutamate transporter appears to be Na+-independent [5, 13] , except in circumstances of extracellular glutamate or glutamine deprivation, when the Na+-dependent variety shows substantial up-regulation [13] . Another odd feature of the cardiac glutamate transporter is that it is strongly inhibited by glutamine (at 20-fold inhibitor excess, glutamine inhibits glutamate transport by about 50%). Moreover, this inhibition appears to be mutual, i.e. glutamate also inhibits glutamine uptake (at 20-fold inhibitor excess there is a 90% inhibition). Furthermore, transport of both glutamine and glutamate are modulated by alterations in external and internal [H']. For example, we have found that inward glutamate transport decreases when there is an outwardly directed proton gradient, whereas under similar conditions the uptake of glutamine is increased [18] . These observations would indicate that during conditions of cardiac acidosis due to hypoxia or ischaemia, when there is an increase in the intracardiac proton concentration, glutamate transport should decrease but the net inward glutamine transport should increase.
Such behaviour has possible beneficial effects in respect of the heart. When we examined the possibility that glutamine could have a cardioprotective effect on the isolated perfused working rat heart, we were gratified to discover that indeed exposure of hearts to glutamine at concentrations of 1.25 mM and above conferred some protection on the heart from the effects of low flow and reperfusion. Thus, in the absence of glutamine, low flow and reperfusion resulted in a failure of cardiac output to a value of about 30% of the pre-ischaemic values [21, 22] . Conversely, in the presence of glutamine, heart performance returned to normal on reperfusion and was even slightly elevated. We have now shown that at the concentration which was maximal for protection of the heart (2.5 mM), glutamine may exert a considerable effect, not just in protecting it but in rescuing it from the effects of low flow and reperfusion, despite its previous lack of exposure to glutamine (Figure 1) . It is particularly noteworthy that the beneficial effects of glutamine on cardiac output are only manifest above the normal plasma concentration of glutamine, although they are maximally observed at concentrations which are no more than four times normal post-absorptive plasma glutamine concentration. The mechanisms of these effects are not understood, but they are obviously of potentially great significance.
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Figure I
Effect of glutamine on post-ischaemic cardiac output in the working rat heart A likely major site for initiation of these effects is the sarcolemma, where the rate of glutamine transport will obviously influence muscle glutamine pool size and thus cell volume. In rat and human skeletal muscle, glutamine transport occurs overwhelmingly by the Na+-dependent transport System N", which also appears to be the most strongly regulated of the amino acid [8,12,13] ). This variety of regulatory mechanism suggests that glutamine exchange between muscle and plasma and the consequent metabolic effects are themselves likely to be affected by numerous physiological and pathophysiological factors such as nutritional status, which alter the concentration of both glutamine and a variety of hormones in the blood.
The mechanism linking glutamine-induced cell swelling to stimulation of glycogen synthesis appears to involve protein kinase signalling cascades, being inhibited both by wortmannin, the phosphatidylinositol 3 kinase inhibitor, and rapamycin, the p70 S6 kinase inhibitor (S. Y. Low, M. J. Rennie and P. M. Taylor, unpublished work).
In contrast, the swelling-induced stimulation of System N" is only inhibited by wortmannin 
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distinct from (and additive to) the effect of hypotonic swelling with or without insulin [28] . Insulin and hypotonic swelling both stimulate glutamine transport by wortmannin-sensitive pathways ( Figure Z) , whereas glutamine itself stimulates its own transport by a mechanism at least partially insensitive to wortmannin. T h e decrease in glutamine transport resulting from hypertonic cell shrinkage is also blocked by wortmannin but not by rapamycin. Thus cell swelling under hypotonic and 'isotonic' conditions (the latter produced, for example, by glutamine, rapamycin or arsenite; see Figure 3 ) results in stimulation of muscle glutamine transport by different mechanisms.
The mechanism by which cell volume is sensed in skeletal muscle is not fully understood. Rapid modulation of glutamine transport by aniso-osmotic exposure is unaffected by anion channel blockers [28] or by release of Ca2' from intra-myotube stores (as we have found using thapsigargin, which does not directly affect glutamine transport). Whereas changes in intracellular solute composition may participate in the sensing mechanism, additional mechanisms responding directly to altered membrane activities or to cell stretch may also be involved, possibly involving cytoskeletal elements. System A (the Nat-dependent insulin-sensitive transporter found in almost all mammalian tissues) is physically associated in the cell membrane with integrin (a3p1) proteins [29] . Regulation of pl integrin-mediated cell adhesion and movement are linked to wortmannin-sensitive pathways [30] , raising the possibility that membrane stretch, for whatever reason, may have a direct effect on the regulation of amino acid-transport systems.
Sarcolemmal glutamine exchange is important for whole-body nitrogen metabolism in health, and muscle is a major site of storage and synthesis of glutamine for export to other tissues in circumstances of disease, injury or stress [ 3 1,321. These pathophysiological circumstances are also known to be associated with decreased intracellular volume of skeletal muscle [33] . Furthermore, muscle growth is promoted by stretch [34] and exercise [35] , and the processes involved may conceivably include stretch-activated signalling mechanisms involved in regulation of protein turnover. There is an intriguing possibility that various membrane-associated signalling mechanisms may be triggered by a variety of physiological and pathophysiological events which themselves both involve and modulate amino acid transporters. Amino acid transport therefore would contribute not only to the delivery of substrates to muscle but also to the signalling of circumstances of metabolic largesse in which anabolism may be sustained. Determining whether such a proposition is true or not and the mechanisms which underpin it are major tasks for the near future. 
